If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,235.00    -20.00 (-1.59%)
Bid:
1,230.00
Ask:
1,255.00
Spread: 25.00 (2.033%)
Market Cap: £172.90m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

17 Feb 2012 09:31

RNS Number : 6261X
Oryx International Growth Fund Ld
17 February 2012
 



ORYX INTERNATIONAL GROWTH FUND LIMITED

 

INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 31 DECEMBER 2011

 

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 October 2011 to 31 December 2011, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

 

Manager's Review

During the period under review, the FTSE Small Cap TR (£) Index returned -1.26% and the FTSE All-Share TR Index (£) returned +8.39%. Against this, the Fund's net asset value rose by 3.7% to 279p per share. Whilst market conditions remain difficult, the Manager believes that there is the potential for corporate activity to occur in the Fund's quoted portfolio and there remains scope for capital appreciation in the unquoted portfolio.

 

 

Material Transactions

Since 1 October 2011, the Company has purchased for cancellation the following shares:

 

14 December 2011 a total of 584,392 ordinary shares at a gross price of £1.90 per share.

19 December 2011 a total of 5,000 ordinary shares at a gross price of £1.90 per share.

28 December 2011 a total of 5,000 ordinary shares at a gross price of £2.00 per share.

9 February 2012 a total of 53,000 ordinary shares at a gross price of £2.02 per share.

 

Material Events

There were no material events during the quarter ended 31 December 2011.

 

 

Report and Accounts

On 25 November 2011, the Company posted its Interim Report for the six months ended 30 September 2011, to Shareholders.

 

 

Financial Highlights

 

 

31 December 2011

30 September 2011

30 June

2011

31 March 2011

31 December 2010

 

 

 

 

 

 

NAV

£2.79

£2.69

£2.96

£2.72

£2.81

 

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5541

 

1.5579

 

1.6055

 

1.6029

 

1.5657

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 31 December 2011

 

% Net Assets

Gleeson (M.J.) Group Plc

7.00

CVS Group Plc

6.71

Redhall Group Plc

6.47

GTL Resources Plc

6.20

Augean Plc

5.47

Guinness Peat Group Plc

5.39

RPC Group Plc

5.28

Orthoproducts Ltd

5.14

Quatro Group Inc

4.99

BBA Aviation Plc

4.28

Idox Plc

4.28

Eckoh Plc

3.97

Assetco Plc

3.87

Catalyst Media Group Plc

3.51

Bavaria Industriekapital Ag

3.14

Sinclair IS Pharma Plc

3.05

Nastor Inv Ltd Zero Redeem Prefer Shares

2.71

Journey Group Plc

2.53

Bionostics Holdings Ltd

2.49

Celsis AG

2.18

85.33

 

 

The financial information for the quarter ended 31 December 2011 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

 

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUUWPUPPUBM
Date   Source Headline
17th Dec 20217:00 amRNSHalf-Yearly Results
10th Dec 202112:50 pmRNSNet Asset Value(s)
17th Nov 20217:00 amRNSHolding(s) in Company
11th Nov 202112:32 pmRNSNet Asset Value(s)
26th Oct 202111:24 amRNSTransaction in Own Shares
25th Oct 202112:09 pmRNSTransaction in Own Shares
11th Oct 202110:25 amRNSNet Asset Value(s)
23rd Sep 20214:32 pmRNSMajor liquidity events totalling £43 million
8th Sep 20212:13 pmRNSNet Asset Value(s)
27th Aug 202112:30 pmRNSResult of Annual General Meeting
9th Aug 20213:12 pmRNSNet Asset Value(s)
27th Jul 20216:00 pmRNSNotice of AGM
14th Jul 202111:45 amRNSNet Asset Value(s)
8th Jul 202111:42 amRNSAnnual Financial Report
9th Jun 20218:24 amRNSNet Asset Value(s)
3rd Jun 20212:44 pmRNSHolding(s) in Company - Replacement
3rd Jun 202112:51 pmRNSHolding(s) in Company
3rd Jun 20217:02 amRNSHolding(s) in Company
3rd Jun 20217:01 amRNSHolding(s) in Company
3rd Jun 20217:00 amRNSHolding(s) in Company
13th May 202111:21 amRNSNet Asset Value(s)
14th Apr 202111:42 amRNSNet Asset Value(s)
24th Mar 202110:26 amRNSHolding(s) in Company
22nd Mar 20216:27 pmRNSHolding(s) in Company
12th Mar 20213:37 pmRNSHolding(s) in Company
12th Mar 202111:01 amRNSNet Asset Value(s)
5th Mar 20219:02 amRNSHolding(s) in Company
4th Mar 202112:30 pmRNSHolding(s) in Company
1st Mar 20211:49 pmRNSTotal Voting Rights
26th Feb 20215:04 pmRNSHolding(s) in Company
25th Feb 20214:21 pmRNSHolding(s) in Company
17th Feb 20211:11 pmRNSHolding(s) in Company
12th Feb 202112:25 pmRNSTransaction in Own Shares
11th Feb 20216:00 pmRNSHolding(s) in Company
11th Feb 202110:49 amRNSNet Asset Value(s)
22nd Jan 20214:00 pmRNSHolding(s) in Company
22nd Jan 202111:09 amRNSHolding(s) in Company
20th Jan 20214:25 pmRNSNet Asset Value(s)
20th Jan 20219:50 amRNSHolding(s) in Company
18th Jan 20213:32 pmRNSHolding(s) in Company
15th Jan 20211:23 pmRNSHolding(s) in Company
4th Jan 20214:28 pmRNSTR-1: Notification of major holdings
4th Jan 20211:38 pmRNSTR1: Notification of major shareholding
4th Jan 202111:26 amRNSHoldings in Company
4th Jan 20217:30 amRNSHolding(s) in Company
31st Dec 20201:04 pmRNSTR-1
23rd Dec 202012:43 pmRNSHolding(s) in Company
21st Dec 20203:57 pmRNSNet Asset Value(s)
11th Dec 20201:05 pmRNSHolding(s) in Company
10th Dec 20201:55 pmRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.